APPlife Digital Solutions (ALDS) 10-K 7 Oct 22 2022 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Jun. 30, 2022	Oct. 06, 2022	Dec. 31, 2021
Details
Registrant CIK	0001755101
Fiscal Year End	--06-30
Document Type	10-K
Document Annual Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	000-54524
Entity Registrant Name	APPLIFE DIGITAL SOLUTIONS INC.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	30-0678378
Entity Address, Address Line One	50 California St
Entity Address, Address Line Two	#1500
Entity Address, City or Town	San Francisco
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94111
Entity Address, Address Description	Address of principal executive offices
City Area Code	415
Local Phone Number	439-5260
Phone Fax Number Description	Registrant's telephone number
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 948,494
Entity Common Stock, Shares Outstanding		148,543,635
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Auditor Firm ID	587
Auditor Name	BSM LLP
Auditor Location	New York, NY

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Current assets
Cash	$ 189,233	$ 250,073
Prepaid expenses	8,038	34,113
Inventories	64,200	48,875
Total assets	261,471	333,061
Current liabilities
Accounts payable and accrued expenses	103,355	266,323
Common stock payable	10,475	0
Notes payable to shareholders	289,319	518,000
Notes payable - current, net	0	77,235
Derivative liabilities	577,180	28,576
Due to officer	0	6,428
Total current liabilities	980,329	896,562
Notes payable to shareholders, noncurrent	100,000	786,925
Total liabilities	1,080,329	1,683,487
Stockholders' deficit
Common stock, $0.001 par value, 500,000,000 shares authorized; 148,543,635 and 135,524,617 shares issued and outstanding as of June 30, 2022 and 2021, respectively	148,545	135,526
Additional paid-in capital	12,410,428	8,350,779
Accumulated (deficit)	(13,377,831)	(9,836,731)
Total stockholders' deficit	(818,858)	(1,350,426)
Total liabilities and stockholders' deficit	$ 261,471	$ 333,061

Consolidated Balance Sheets - P

Consolidated Balance Sheets - Parenthetical - $ / shares	Jun. 30, 2022	Jun. 30, 2021
Details
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	500,000,000	500,000,000
Common Stock, Shares, Issued	148,543,635	135,524,617
Common Stock, Shares, Outstanding	148,543,635	135,524,617

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Details
Revenue	$ 28,162	$ 4,951
Cost of goods sold	(25,907)	(3,682)
Gross profit	2,255	1,269
Operating expenses	3,012,414	3,719,355
Total operating expenses	3,012,414	3,719,355
Loss from operations	(3,010,159)	(3,718,086)
Other income (expense)
Interest expense	(500,919)	(561,899)
Loss on extension of notes payable	0	(41,214)
Gain on settlement of debt	48,619	0
Change in fair value of common stock	(11,283)	0
Change in fair value of derivative liability	(67,358)	94,359
Net loss before provision for income taxes	(3,541,100)	(4,226,840)
Provision for income taxes	0	0
Net loss	$ (3,541,100)	$ (4,226,840)
Basic and diluted loss per share	$ (0.07)	$ (0.10)
Average number of common shares outstanding - basic and diluted	51,075,639	40,380,171

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Deficit - USD ($)	Common Stock	Additional Paid-in Capital	Retained Earnings	Total
Stockholders' Equity Attributable to Parent, Beginning Balance at Jun. 30, 2020	$ 127,037	$ 5,037,883	$ (5,609,891)	$ (444,971)
Shares, Outstanding, Beginning Balance at Jun. 30, 2020	127,037,531
Common stock issued for cash, Value	$ 1,200	118,800	0	120,000
Common stock issued for cash, Shares	1,200,000
Stock compensation expense	$ 3,000	2,057,245	0	2,060,245
Common stock issued for services, Value	$ 3,268	565,368	0	568,636
Common stock issued for services, Shares	3,265,327
Issuance of common stock payable	$ 140	25,096	0	25,236
Issuance of common stock payable, Shares	140,199
Shares issued for prepayment penalty	$ (277)	(45,237)	0	(45,514)
Shares issued for prepayment penalty, Shares	(277,012)
Payment of notes payable with issuance of common stock, Value	$ 604	115,580	0	116,184
Payment of notes payable with issuance of common stock, Shares	604,548
Eliminate derivative liability upon repayment of debt	$ 0	125,238	0	125,238
Equity component of issuance of convertible notes	0	260,332	0	260,332
Net loss	0	0	(4,226,840)	(4,226,840)
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2021	$ 135,526	8,350,779	(9,836,731)	(1,350,426)
Shares, Outstanding, Ending Balance at Jun. 30, 2021	135,524,617
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture	3,000,000
Shares issued for prepayment penalty	$ 277	45,237	0	45,514
Shares issued for prepayment penalty, Shares	277,012
Common stock issued for cash, Value	$ 5,200	514,800	0	520,000
Common stock issued for cash, Shares	5,200,000
Stock compensation expense	$ 4,000	2,010,612	0	2,014,612
Common stock issued for services, Value	$ 3,819	140,322	0	144,141
Common stock issued for services, Shares	3,819,018
Issuance of common stock payable				25,236
Issuance of common stock payable, Shares	140,199
Shares issued for prepayment penalty				0
Eliminate derivative liability upon repayment of debt				0
Net loss	$ 0	0	(3,541,100)	(3,541,100)
Stockholders' Equity Attributable to Parent, Ending Balance at Jun. 30, 2022	$ 148,545	12,410,428	(13,377,831)	(818,858)
Shares, Outstanding, Ending Balance at Jun. 30, 2022	148,543,635
Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture	4,000,000
Shares issued for prepayment penalty				0
Settlement of notes payable with issuance of options to purchase common stock	$ 0	$ 1,393,915	$ 0	$ 1,393,915

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (3,541,100)	$ (4,226,840)
Adjustment to reconcile change in net loss to net cash used in operating activities
Amortization	192,396	293,499
Interest expense	137,924	0
Issuance of common stock for services	144,141	568,636
Shares issued for prepayment penalty	0	45,514
Loss on extension of notes payable	0	41,214
Stock compensation expense	2,014,612	2,060,245
Change in fair value of derivative liability	67,358	(94,359)
Gain on settlement of debt	(48,619)	0
Common stock payable	10,475	(54,764)
Changes in operating assets and liabilities
Accounts receivable	0	7,574
Prepaid expenses and other current assets	26,075	354,313
Inventories	(15,325)	(5,200)
Accounts payable and accrued expenses	127,651	191,534
Net Cash Provided by (Used in) Operating Activities	(884,412)	(818,634)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from notes payable to shareholders	350,000	1,048,000
Proceeds from issuance of common stock	520,000	120,000
Payment on notes payable	(40,000)	(185,000)
Payment on amounts due to officer	(6,428)	0
Net cash provided from financing activities	823,572	983,000
Net increase (decrease) in cash and cash equivalents	(60,840)	164,366
Cash and cash equivalents, beginning of year	250,073	85,707
Cash and cash equivalents, end of year	189,233	250,073
Supplemental disclosure of cash flow information
Cash paid for interest	0	16,153
Cash paid for taxes	0	0
Non-cash investing and financing activities
Eliminate derivative liability upon repayment of debt	0	125,238
Issuance of common stock payable	0	25,236
Equity component of issuance of convertible notes	0	260,332
Payment of notes payable with issuance of common stock	0	74,970
Increase in derivative liability upon issuance of convertible note	484,374	0
Payment of notes payable with issuance of options to purchase common stock	$ 1,393,915	$ 0

Note 1 - Organization, Going Co

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies	12 Months Ended
	Jun. 30, 2022
Notes
Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies	Note 1 – Organization, Going Concern and Summary of Significant Accounting Policies Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. The Company’s mission is using digital technology to create APPs and websites that make life, business and living easier, more efficient and just smarter. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s subscription service that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. Office Hop, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. Office Hop is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms. Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The current pandemic known as COVID-19 as described in Note 5, creates additional uncertainty. There have been outbreaks in several countries, including the United States, of the highly transmissible and pathogenic coronavirus (“COVID-19”). The outbreak of such COVID-19 resulted in a widespread health crisis that adversely affected general commercial activity and the economies and financial markets of many countries, including the United States. Although to date, the Company has not been adversely affected by COVID-19, the measures taken by the governments of countries affected could adversely affect the Company’s business, financial condition, and results of operations. The accompanying consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern. Basis of Presentation The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. All intercompany transactions have been eliminated in consolidation. Cash and Cash Equivalents For the purpose of the consolidated statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less. Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of June 30, 2022. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California. Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, BCF (Beneficial Conversion Feature) liabilities feature of convertible debt, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates. Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, ” Revenue from Contracts with Customers, ” Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date. Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. There were no potentially dilutive securities for the years ended June 30, 2022 and 2021. Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s financial statements for cash, accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these financial instruments. Derivative Liability FASB ASC 815, Derivatives and Hedging Inventories Inventories, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of June 30, 2022, the Company had inventories of $64,200. The Company has no allowance for inventory reserves.

Note 2 - Notes Payable

Note 2 - Notes Payable	12 Months Ended
	Jun. 30, 2022
Notes
Note 2 - Notes Payable	Note 2 – Notes payable In March 2018, the Company issued notes that carry an 8% annual interest rate and mature through December 31, 2019. In December 2019, $5,119 of principal was converted into Company common stock and payments were made of $11,381. In March 2020, the note was exchanged for a convertible promissory note that accrues interest at 10% per annum and matured on March 11, 2021. The principal balance of the new note is $77,235 as of June 30, 2021. On August 21, 2021, The Company settled this note after the holder agreed to accept $40,000 payment to satisfy the total amount due. Hence, no additional interest was charged on the note.

Note 3 - Notes payable to share

Note 3 - Notes payable to shareholders	12 Months Ended
	Jun. 30, 2022
Notes
Note 3 - Notes payable to shareholders	Note 3 – Notes payable to shareholders On July 3, 2019, the Company issued a $250,000 convertible promissory note (the “July 2019 Note”) to a lender (the “Lender”). According to the terms the Lender funded the July 2019 Note as follows: $100,000 upon the execution of the Note, $50,000 on August 1, 2019, $50,000 on September 1, 2019, and the remaining $50,000 on October 1, 2019. The outstanding principal balance of the Note shall bear interest at the rate of twelve percent (12%) per annum. The balance of the July 2019 Note was $250,000 on June 30, 2021 and matures July 03, 2021. On August 28, 2021, the investor agreed to extend the note till July 03, 2022. On June 8, 2022 the Company converted the outstanding $250,000 in principal and $85,266 in interest into 1,672,995 options to purchase common stock. The options were valued at $26,959, in the aggregate, using Black Scholes. On November 22, 2019, Company issued a $170,000 convertible promissory note (the “November 2019 Note”) to the Lender that accrues interest at 12% per annum. The July and November Notes contain embedded derivatives, see Note 7. On June 8, 2022 the Company converted the outstanding $170,000 in principal and $51,922 in interest into 651,726 options to purchase common stock. The options were valued at $11,887, in the aggregate, using Black Scholes. On July 14, 2020 and October 21, 2020, the Company sold convertible notes (“2020 Notes”) bearing 12% interest in the principal amounts of $340,000 and $348,000, respectively. Subject to certain ownership limitations, the notes will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion price of $0.144. The beneficial conversion features of these notes were valued at $85,000 and $135,333, respectively, and are amortized over the life of the notes. On June 8, 2022 the Company converted both loans, in which on that date, the outstanding $340,000 and $348,000 in principle, and $77,576 and $68,075 in interest, were converted into 2,896,611 and 2,895,431 options to purchase common stock. The options were valued at $69,310, and $69,043, respectively, in the aggregate, using Black Scholes. On January 12, 2021, the Company sold convertible notes bearing 12% interest on the principal amount of $360,000, respectively. The principal amount was agreed to be paid in two tranches of $180,000 each, received on February 19, 2021 and March 08, 2021. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $0.144. The beneficial conversion features of this note were valued at $35,500 and $7,500 for each tranche received and are amortized over the life of the note. On February 04, 2022, the Company sold convertible note bearing 12% interest in the principal amount of $350,000 (“February 2022 Notes”). The note will be paid in three tranches with first tranche of $100,000 received on March 28, 2022. The second and third tranches of $150,000 and $100,000 each, were received on May 3, 2022, and June 21, 2022, respectively. The note is subject to certain ownership limitations and will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion rate of $ 0.013. The February 2022 Notes contain embedded derivatives, see Note 7. On June 8, 2022, the Company converted the July 2019 Notes, November 2019 Note and the 2020 Notes (collectively “Converted Notes”), with an aggregate principal balance of $1,108,000 and $282,838 of accrued interest into stock options. The options expire in five years with the exercise prices ranging between $0.14 and $0.34. The options were valued at $216,981, in the aggregate, using Black Scholes. Amount Balance of notes payable, net of discount on June 30, 2021 $ 1,382,160 Issuances of debt, net of discount 350,000 Amortization of debt discount 192,396 Embedded Conversion Feature - debt discount (350,000) Payments on notes payable (40,000) Settlement of notes payable less accrued interest (1,108,000) Loss on the forgiveness of debt (37,237) Balance of notes payable, net of discount as of June 30, 2022 $ 389,319

Note 4 - Related Party Transact

Note 4 - Related Party Transactions	12 Months Ended
	Jun. 30, 2022
Notes
Note 4 - Related Party Transactions	Note 4 – Related Party Transactions Due to Officer During the year ending June 30, 2018, the Company received advances from its officer to pay for certain operating expenses. The balance due to the officer at June 30, 2022 and 2021 was $0 and $6,428, respectively. There are no definitive repayment terms and no interest is accruing on these advances. Notes Payable to Shareholder During the year ended June 30, 2022, the Company received $350,000 in notes payable to related parties, see note 3, notes payable to shareholders for detail. Additionally, during the year ended June 30, 2022, the Company and the shareholder agreed to covert an aggregate $1,108,000 and $282,838 in outstanding principal and interest into an aggregate 8,106,723 options to purchase common stock, see note 7, stockholders’ equity for further detail.

Note 5 - Concentrations

Note 5 - Concentrations	12 Months Ended
	Jun. 30, 2022
Notes
Note 5 - Concentrations	Note 5 – Concentrations Cash Concentration The Company maintains its cash and cash equivalents at financial institutions in the United States and China, which may, at times, exceed federally insured limits or similar limits in foreign jurisdictions. At June 30, 2022, the Company’s cash balance did not exceed the FDIC insurance limit. The Company has not experienced any losses in such accounts.

Note 6 - Commitments and Contin

Note 6 - Commitments and Contingencies	12 Months Ended
	Jun. 30, 2022
Notes
Note 6 - Commitments and Contingencies	Note 6 – Commitments and Contingencies Legal Matters From time to time the Company may be involved in certain legal actions and claims arising in the ordinary course of business. The Company was not a party to any specific legal actions or claims at June 30, 2022. Other Risks There have been outbreaks in several countries, including the United States, of the highly transmissible and pathogenic coronavirus (“COVID-19”). The outbreak of such COVID-19 resulted in a widespread health crisis that adversely affected general commercial activity and the economies and financial markets of many countries, including the United States. Although to date, the Company has not been adversely affected by COVID-19, the measures taken by the governments of countries affected could adversely affect the Company’s business, financial condition, and results of operations.

Note 7 - Stockholders' Equity (

Note 7 - Stockholders' Equity (Deficit)	12 Months Ended
	Jun. 30, 2022
Notes
Note 7 - Stockholders' Equity (Deficit)	Note 7 – Stockholders’ Equity (Deficit) As of June 30, 2022, and June 30, 2021, there were 148,543,635 and 135,524,617 shares of common stock issued and outstanding, respectively. During the years ended June 30, 2022 and 2021, the Company issued 5,200,000 and 1,200,000 shares of common stock pursuant to subscriptions agreements for $520,000 and $120,000, respectively, or $0.10 per share. Common stock issued for services During the years ended June 30, 2022 and 2021, the Company issued 3,819,018 and 3,265,327 shares of common stock to third parties for services valued at $144,141 and $568,636, respectively, with prices between $0.02 and $0.24 per share. Issuance of common stock payable During the year ended June 30, 2021, the Company issued 140,199 shares of common stock owed to third parties for services rendered during the year, valued at $25,236. The Company has a balance of $10,475 of common stock payable as of the year ended June 30, 2022. Restricted stock and Stock options During the year ended June 30, 2022, and 2021, the Company recognized stock compensation expense on outstanding restricted stock awards of $2,014,612 and $2,060,245, respectively. During the years ended June 30, 2022 and 2021, the Company granted 8,106,723 and 4,094,959 stock options, in the aggregate, to its board members and consultants. The options granted in fiscal year 2022 vest pro-rata over the member’s term, have exercise prices between $0.02 and $0.03 and expire in five years from the date of grant. The options 8,106,723 options were issued on June 8, 2022 and were issued in exchange for $1,309,838 in outstanding principal and interest respective (see note 5) from notes payable. On June 15, 2022, the Company granted 2,000,000 stock options to its attorney as compensation. The options vest pro-rata over five years, have exercise price of $0.03 and expire in five years from the date of grant. Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – July 1, 2020 - $ - - Granted 4,094,959 0.15 5 Exercised - - - Outstanding – June 30, 2021 4,094,959 $ 0.15 5 Granted 19,407,076 0.10 4.78 Exercised - - - Outstanding – June 30, 2022 23,502,035 $ 0.11 2.92 The Company recognized $233,471 and $488,296 of expense during the years ended June 30, 2022 and 2021, respectively, in connection with the options and valued with Black Scholes using the following inputs: Year Ended June 30, 2022 Stock price $ 0.02 - 0.03 Exercise price $ 0.02 – 0.34 Expected term (in years) 4.94 – 5.00 Volatility (annual) 141.5% - 271.1 % Risk-free rate 1.39% - 2.94 % Year Ended June 30, 2021 Stock price $ 0.11 - 0.20 Exercise price $ 0.22 - 0.37 Expected term (in years) 3 – 5 Volatility (annual) 187% – 271.1 % Risk-free rate 0.05% – 0.12 % Shares issued for prepayment penalty On September 29, 2020, the Company paid $81,675 towards one of its outstanding notes, which includes principal of $55,000, prepayment penalty of $21,175 and accrued interest of $5,500. As an inducement to pay off the note early, the Company issued 153,410 shares of common stock valued at $0.20 per share, or $30,682 to the Investor (see Note 2). On October 29, 2020, the Company paid $81,553 toward the final tranche of the notes issued on October 1, 2019, which consists of principal of $55,000, interest of $5,410 and a prepayment penalty of $21,143. The Company also issued 123,602 shares to the creditor valued at $14,832 in conjunction with the prior extension of this note. Equity component of issuance of convertible notes On July 14, 2020 and October 21, 2020, the Company sold convertible notes bearing 12% interest in the principal amounts of $340,000 and $348,000, respectively. Subject to certain ownership limitations, the notes will be convertible at the option of the holder at any time into shares of the Company’s common stock at an effective conversion price of $0.144. The embedded conversion features of these notes were valued at $85,000 and $135,333, respectively, and is amortized over the life of the notes. On January 12, 2021, the Company sold convertible notes bearing 12% interest on the principal amount of $360,000, respectively (see Note 2). The embedded conversion features of the notes were valued at $40,000 and is amortized over the life of the notes.

Note 8 - Derivative Liability

Note 8 - Derivative Liability	12 Months Ended
	Jun. 30, 2022
Notes
Note 8 - Derivative Liability	Note 8 – Derivative Liability The Company issued debts that consist of the issuance of convertible notes with variable conversion provisions. The conversion terms of the convertible notes are variable based on certain factors, such as the future price of the Company’s common stock. The number of shares of common stock to be issued is based on the future price of the Company’s common stock. The number of shares of common stock issuable upon conversion of the promissory note is indeterminate. Pursuant to ASC 815-15 Embedded Derivatives, the fair values of the variable conversion options and shares to be issued were recorded as derivative liabilities on the issuance date and revalued at each reporting period. A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the year ended June 30, 2022 is as follows: Year Ended June 30, 2022 Stock price $ 0.02 – 0.04 Exercise price $ 0.01 – 0.36 Contractual term (in years) 0.14 – 5.00 Volatility (annual) 166% - 201% Risk-free rate 0.04% - 3.03% The foregoing assumptions are reviewed quarterly and are subject to change based primarily on management’s assessment of the probability of the events described occurring. Accordingly, changes to these assessments could materially affect the valuations. Financial Liabilities Measured at Fair Value on a Recurring Basis Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability – warrants and derivative liabilities: Fair value measured at June 30, 2022 Quoted prices in active Significant other Significant markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2022 Derivative liability $ - $ - $ 577,180 $ 577,180 Total $ - $ - $ 577,180 $ 577,180 Fair value measured at June 30, 2021 Quoted prices in active Significant other Significant markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2021 Derivative liability $ - $ - $ 28,576 $ 28,576 Total $ - $ - $ 28,576 $ 28,576 The fair value accounting standards define fair value as the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is determined based upon assumptions that market participants would use in pricing an asset or liability. Fair value measurements are rated on a three-tier hierarchy as follows: · Level 1 inputs: Quoted prices (unadjusted) for identical assets or liabilities in active markets; · Level 2 inputs: Inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly; and · Level 3 inputs: Unobservable inputs for which there is little or no market data, which require the reporting entity to develop its own assumptions. There were no transfers between Level 1, 2 or 3 during the years ended June 30, 2022 and 2021. In the year ending June 30, 2021, the Company recorded a decrease in fair value of derivative liability of $94,356. In the year ending June 30, 2022, the Company recorded an increase in fair value of derivative liability of $130,593. The following table presents the activity for derivative liabilities measured at estimated fair value: Derivative Liability Balance as of June 30, 2020 $ 248,173 Additions during the period - Change in fair value (94,357) Change due to conversion / exercise / redemptions (125,240) Balance as of June 30, 2021 $ 28,576 Additions during the period 484,376 Change in fair value 67,360 Change due to conversion / exercise / redemptions (3,132) Balance as of June 30, 2022 $ 577,180 The balance of the derivative liability at June 30, 2022, and 2021 was $577,180 and $28,576, respectively.

Note 9 - Income Taxes

Note 9 - Income Taxes	12 Months Ended
	Jun. 30, 2022
Notes
Note 9 - Income Taxes	Note 9 – Income Taxes The Company files corporate income tax returns in the United States (federal) and in Delaware. Since the Company incurred net operating losses in every tax year since inception, the 2020, 2021 and 2022 income tax returns are subject to examination and adjustments by the IRS for at least three years following the year in which the tax attributes are utilized. As of June 30, 2022, the Company had federal net operating loss carry forwards of $5,445,000 and state net operating loss carryforwards of $4,053,000. Federal net operating losses generated since inception amounting to $5,273,000, no longer have an expiration for the years the Company has been operating. State net operating loss carryforwards will begin to expire in 2039 through 2042. The Company also had net operating losses of $23,000 in China which will expire in 2032. Net operating loss carry forwards may be limited in available usage under Internal Revenue Code 382 as a result of the issuance of additional stock. The Company is currently reviewing the limitation. Other than minimum taxes, the company does not incur a provision for income taxes because the Company has historically incurred operating losses and maintains a full valuation allowance against its net deferred tax assets due to the uncertainty surrounding the realizability of the benefit, based on a more likely than not criteria and in consideration of available positive and negative evidence. Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and amounts used for income tax purposes. Significant components of the Company's deferred tax assets and liabilities consist of the following: Year Ended June 30, 2022 2021 Deferred Tax Assets Net Operating Loss Carryforward $ 1,427,731 $ 1,078,203 Stock Based Compensation 1,193,811 592,103 Unrealized loss on Debt conversion 10,036 10,036 Valuation Allowance (2,631,578) (1,680,342) Net Deferred Tax Assets $ - $ - Reconciliation of the statutory federal income tax to the Company’s effective tax: Year Ended June 30, 2022 2021 % % Statutory federal tax rate 21.00 % 21.00 % State taxes, net of federal benefit 6.26 % 3.99 % Non-deductible Stock Compensation - % (1.61) % Other (0.40) % 0.47 % Valuation Allowance (26.86) % (23.85) % Provision for income taxes - % - %

Note 10 - Subsequent Events

Note 10 - Subsequent Events	12 Months Ended
	Jun. 30, 2022
Notes
Note 10 - Subsequent Events	Note 10 – Subsequent Events The Company has evaluated subsequent events through the filing of this Form 10-K and determined that no material events occurred.

Note 1 - Organization, Going _2

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Organization (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Organization	Organization APPlife Digital Solutions Inc. (the “Company”) is a business incubator and portfolio manager that uses digital technology to create and invest in e-commerce and cloud-based solutions. The Company was formed March 5, 2018 in Nevada and has offices in San Francisco, California and Shanghai, China. The Company’s mission is using digital technology to create APPs and websites that make life, business and living easier, more efficient and just smarter. Rooster Essentials APP SPV, LLC (the “Rooster”), incorporated on April 9, 2019, is a wholly owned subsidiary of the Company. Rooster is a fully customizable men’s subscription service that delivers daily use grooming needs and essential items. B2BCHX SPV LLC (the “B2BCHX”), incorporated on June 5, 2019, is a wholly owned subsidiary of the Company. B2BCHX does an independent background check on mainland Chinese companies for small businesses globally. Office Hop, incorporated on January 28, 2021, is a wholly owned subsidiary of the Company. Office Hop is a global sharing model platform for short term rentals of office and meeting rooms. Users can find an office or conference space for half-day, full-day, or weekly rental. Hosts can list their spare office or meeting rooms.

Note 1 - Organization, Going _3

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Going Concern (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Going Concern	Going Concern The Company has generated losses and negative cash flows from operations since inception. The Company has historically financed its operations from equity financing. The Company anticipates additional equity financings to fund operations in the future. Should management fail to adequately address the issue, the Company may have to reduce its business activities or curtail its operations. There can be no assurance that any additional financings, would be available to the Company on satisfactory terms and conditions if at all. The current pandemic known as COVID-19 as described in Note 5, creates additional uncertainty. There have been outbreaks in several countries, including the United States, of the highly transmissible and pathogenic coronavirus (“COVID-19”). The outbreak of such COVID-19 resulted in a widespread health crisis that adversely affected general commercial activity and the economies and financial markets of many countries, including the United States. Although to date, the Company has not been adversely affected by COVID-19, the measures taken by the governments of countries affected could adversely affect the Company’s business, financial condition, and results of operations. The accompanying consolidated financial statements have been prepared on a going concern basis of accounting, which contemplates continuity of operations, realization of assets and classification of liabilities and commitments in the normal course of business. The accompanying consolidated financial statements do not reflect any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classifications of liabilities that might result if the Company is unable to continue as a going concern.

Note 1 - Organization, Going _4

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Basis of Presentation (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States, or U.S. GAAP. All intercompany transactions have been eliminated in consolidation.

Note 1 - Organization, Going _5

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Cash and Cash Equivalents (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents For the purpose of the consolidated statement of cash flows, the Company considers cash equivalents to include cash and investments with an original maturity of three months or less.

Note 1 - Organization, Going _6

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Income Taxes (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Income Taxes	Income Taxes The Company has adopted guidance issued by the FASB that clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements and prescribes a recognition threshold of more likely than not and a measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. In making this assessment, a company must determine whether it is more likely than not that a tax position will be sustained upon examination, based solely on the technical merits of the position and must assume that the tax position will be examined by taxing authorities. The Company’s policy is to include interest and penalties related to unrecognized tax benefits in income tax expense. The Company had no accrual for interest or penalties as of June 30, 2022. The Company files income tax returns with the Internal Revenue Service (“IRS”) and the state of California.

Note 1 - Organization, Going _7

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Use of Estimates (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Use of Estimates	Use of Estimates Generally accepted accounting principles require that the consolidated financial statements include estimates by management in the valuation of certain assets and liabilities. Significant matters requiring the use of estimates and assumptions include, but are not necessarily limited to, fair value of the Company’s stock, stock-based compensation, BCF (Beneficial Conversion Feature) liabilities feature of convertible debt, and valuation allowance relating to the Company’s deferred tax assets. Management uses its historical records and knowledge of its business in making these estimates. Management believes that its estimates and assumptions are reasonable, based on information that is available at the time they are made. Accordingly, actual results could differ from those estimates.

Note 1 - Organization, Going _8

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Revenue Recognition (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Revenue Recognition	Revenue Recognition The Company will recognize revenue from the sale of products and services in accordance with ASC 606, ” Revenue from Contracts with Customers, ”

Note 1 - Organization, Going _9

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Stock Based Compensation (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Stock Based Compensation	Stock Based Compensation The Company accounts for share-based compensation in accordance with the fair value recognition provision of FASB ASC 718, Compensation – Stock Compensation (“ASC 718”), prescribes accounting and reporting standards for all share-based payment transactions in which employee services are acquired. Transactions include incurring liabilities, or issuing or offering to issue shares, options, and other equity instruments such as employee stock ownership plans and stock appreciation rights. Share-based payments to employees, including grants of employee stock options, are recognized as compensation expense in the consolidated financial statements based on the estimated grant date fair values. That expense is recognized over the period during which an employee is required to provide services in exchange for the award, known as the requisite service period (usually the vesting period). The Company accounts for share-based compensation issued to non-employees and consultants in accordance with the provisions of FASB ASC 505, Equity–based Payments to Non-Employees (“ASC 505”). Measurement of share-based payment transactions with non-employees is based on the fair value of whichever is more reliably measurable: (a) the goods or services received; or (b) the equity instruments issued. The fair value of the share-based payment transaction is determined at the earlier of performance commitment date or performance completion date.

Note 1 - Organization, Going_10

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Net Loss per Share (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Net Loss per Share	Net Loss per Share Basic net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period, increased by potentially dilutive common shares ("dilutive securities") that were outstanding during the period. Dilutive securities include stock options and warrants granted, convertible debt, and convertible preferred stock. There were no potentially dilutive securities for the years ended June 30, 2022 and 2021.

Note 1 - Organization, Going_11

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Fair Value of Financial Instruments (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company follows FASB ASC 820, Fair Value Measurements and Disclosures Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date. Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date. Level 3 Pricing inputs that are generally unobservable inputs and not corroborated by market data. Financial assets are considered Level 3 when their fair values are determined using pricing models, discounted cash flow methodologies or similar techniques and at least one significant model assumption or input is unobservable. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. If the inputs used to measure the financial assets and liabilities fall within more than one level described above, the categorization is based on the lowest level input that is significant to the fair value measurement of the instrument. The carrying amounts reported in the Company’s financial statements for cash, accounts payable and accrued expenses approximate their fair value because of the immediate or short-term nature of these financial instruments.

Note 1 - Organization, Going_12

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Derivative Liability (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Derivative Liability	Derivative Liability FASB ASC 815, Derivatives and Hedging

Note 1 - Organization, Going_13

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Inventories (Policies)	12 Months Ended
	Jun. 30, 2022
Policies
Inventories	Inventories Inventories, consisting of raw materials, work in process and products available for sale, are primarily accounted for using the first-in, first-out method (“FIFO”), and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns to product vendors. As of June 30, 2022, the Company had inventories of $64,200. The Company has no allowance for inventory reserves.

Note 3 - Notes payable to sha_2

Note 3 - Notes payable to shareholders: Schedule of Debt (Tables)	12 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of Debt	Amount Balance of notes payable, net of discount on June 30, 2021 $ 1,382,160 Issuances of debt, net of discount 350,000 Amortization of debt discount 192,396 Embedded Conversion Feature - debt discount (350,000) Payments on notes payable (40,000) Settlement of notes payable less accrued interest (1,108,000) Loss on the forgiveness of debt (37,237) Balance of notes payable, net of discount as of June 30, 2022 $ 389,319

Note 7 - Stockholders' Equity_2

Note 7 - Stockholders' Equity (Deficit): Schedule of Stock Option Activity (Tables)	12 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of Stock Option Activity	Options Weighted Average Exercise Price per Share Weighted Average Remaining Life (Years) Outstanding – July 1, 2020 - $ - - Granted 4,094,959 0.15 5 Exercised - - - Outstanding – June 30, 2021 4,094,959 $ 0.15 5 Granted 19,407,076 0.10 4.78 Exercised - - - Outstanding – June 30, 2022 23,502,035 $ 0.11 2.92

Note 7 - Stockholders' Equity_3

Note 7 - Stockholders' Equity (Deficit): Schedule of Assumptions Used (Tables)	12 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of Assumptions Used	Year Ended June 30, 2022 Stock price $ 0.02 - 0.03 Exercise price $ 0.02 – 0.34 Expected term (in years) 4.94 – 5.00 Volatility (annual) 141.5% - 271.1 % Risk-free rate 1.39% - 2.94 % Year Ended June 30, 2021 Stock price $ 0.11 - 0.20 Exercise price $ 0.22 - 0.37 Expected term (in years) 3 – 5 Volatility (annual) 187% – 271.1 % Risk-free rate 0.05% – 0.12 %

Note 8 - Derivative Liability_

Note 8 - Derivative Liability: Schedule of valuation methodology (Tables)	12 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of valuation methodology	A summary of quantitative information with respect to valuation methodology and significant unobservable inputs used for the Company’s common stock purchase warrants that are categorized within Level 3 of the fair value hierarchy for the year ended June 30, 2022 is as follows: Year Ended June 30, 2022 Stock price $ 0.02 – 0.04 Exercise price $ 0.01 – 0.36 Contractual term (in years) 0.14 – 5.00 Volatility (annual) 166% - 201% Risk-free rate 0.04% - 3.03%

Note 8 - Derivative Liability_2

Note 8 - Derivative Liability: Fair Value, Liabilities Measured on Recurring Basis (Tables)	12 Months Ended
	Jun. 30, 2022
Tables/Schedules
Fair Value, Liabilities Measured on Recurring Basis	Financial liabilities measured at fair value on a recurring basis are summarized below and disclosed on the balance sheet under Derivative liability – warrants and derivative liabilities: Fair value measured at June 30, 2022 Quoted prices in active Significant other Significant markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2022 Derivative liability $ - $ - $ 577,180 $ 577,180 Total $ - $ - $ 577,180 $ 577,180 Fair value measured at June 30, 2021 Quoted prices in active Significant other Significant markets observable inputs unobservable inputs Fair value at (Level 1) (Level 2) (Level 3) June 30, 2021 Derivative liability $ - $ - $ 28,576 $ 28,576 Total $ - $ - $ 28,576 $ 28,576

Note 8 - Derivative Liability_3

Note 8 - Derivative Liability: Schedule of activity for derivative liabilities measured at estimated fair value (Tables)	12 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of activity for derivative liabilities measured at estimated fair value	The following table presents the activity for derivative liabilities measured at estimated fair value: Derivative Liability Balance as of June 30, 2020 $ 248,173 Additions during the period - Change in fair value (94,357) Change due to conversion / exercise / redemptions (125,240) Balance as of June 30, 2021 $ 28,576 Additions during the period 484,376 Change in fair value 67,360 Change due to conversion / exercise / redemptions (3,132) Balance as of June 30, 2022 $ 577,180

Note 9 - Income Taxes_ Schedule

Note 9 - Income Taxes: Schedule of Deferred Tax Assets (Tables)	12 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of Deferred Tax Assets	Year Ended June 30, 2022 2021 Deferred Tax Assets Net Operating Loss Carryforward $ 1,427,731 $ 1,078,203 Stock Based Compensation 1,193,811 592,103 Unrealized loss on Debt conversion 10,036 10,036 Valuation Allowance (2,631,578) (1,680,342) Net Deferred Tax Assets $ - $ -

Note 9 - Income Taxes_ Schedu_2

Note 9 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Tables)	12 Months Ended
	Jun. 30, 2022
Tables/Schedules
Schedule of Effective Income Tax Rate Reconciliation	Year Ended June 30, 2022 2021 % % Statutory federal tax rate 21.00 % 21.00 % State taxes, net of federal benefit 6.26 % 3.99 % Non-deductible Stock Compensation - % (1.61) % Other (0.40) % 0.47 % Valuation Allowance (26.86) % (23.85) % Provision for income taxes - % - %

Note 1 - Organization, Going_14

Note 1 - Organization, Going Concern and Summary of Significant Accounting Policies: Inventories (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Details
Inventories	$ 64,200	$ 48,875

Note 2 - Notes Payable (Details

Note 2 - Notes Payable (Details) - USD ($)		1 Months Ended			12 Months Ended
	Aug. 21, 2021	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2018	Jun. 30, 2021	Jun. 30, 2022
Payment of notes payable with issuance of common stock, Value					$ 116,184
Notes payable - current, net					$ 77,235	$ 0
March 2018 Note
Debt Instrument, Interest Rate During Period				8%
Debt Instrument, Maturity Date				Dec. 31, 2019
Payment of notes payable with issuance of common stock, Value			$ 5,119
Payments on notes payable			$ 11,381
March 2020 Note
Debt Instrument, Maturity Date		Mar. 11, 2021
Debt Instrument, Maturity Date		10%
Notes payable - current, net						$ 77,235
Settlement Payment on Debt	$ 40,000

Note 3 - Notes payable to sha_3

Note 3 - Notes payable to shareholders (Details) - USD ($)

12 Months Ended

Jun. 08, 2022

Aug. 28, 2021

Oct. 21, 2020

Jul. 14, 2020

Nov. 22, 2019

Jul. 03, 2019

Jun. 30, 2022

Jun. 30, 2021

Feb. 04, 2022

Mar. 08, 2021

Jan. 19, 2021

Jan. 12, 2021

Notes payable - current, net

$ 0

$ 77,235

Payment of notes payable with issuance of common stock, Value

$ 116,184

July 2019 Note

Aggregate Principal Balance on Converted Notes

$ 1,108,000

July 2019 Note | Lender

Principal amount

$ 250,000

Debt Instrument, Interest Rate During Period

12%

Notes payable - current, net

250,000

Debt Instrument, Maturity Date

Jul. 03, 2022

Debt Instrument, Maturity Date

26,959

November 2019 Note | Lender

Principal amount

$ 170,000

Debt Instrument, Interest Rate During Period

12%

Debt Instrument, Maturity Date

11,887

April 2020 Note | Investor

Principal amount

$ 348,000

$ 340,000

Payment of notes payable with issuance of common stock, Value

$ 0.12

$ 0.12

Debt Instrument, Convertible, Conversion Price

$ 0.144

$ 0.144

Embedded Conversion Feature

$ 135,333

$ 85,000

July 2020 Note | Investor

Debt Instrument, Maturity Date

69,310

October 2020 Note | Investor

Debt Instrument, Maturity Date

69,043

January 2021 Note

Debt Instrument, Maturity Date

$ 216,981

Accrued Interest on Converted Notes

$ 282,838

January 2021 Note | Investor

Principal amount

$ 360,000

Debt Instrument, Maturity Date

12%

January 2021 Note | Tranches 1

Principal amount

$ 180,000

Embedded Conversion Feature

$ 35,500

January 2021 Note | Tranches 2

Principal amount

180,000

Embedded Conversion Feature

$ 7,500

February 2022 Note | Investor

Principal amount

$ 350,000

Debt Instrument, Maturity Date

12%

February 2022 Note | Tranches 1

Principal amount

$ 100,000

Note 3 - Notes payable to sha_4

Note 3 - Notes payable to shareholders: Schedule of Debt (Details) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Details
Notes Payable	$ 389,319	$ 1,382,160
Proceeds from Issuance of Long-Term Debt	350,000
Amortization of debt discount	192,396
Embedded Conversion Feature - debt discount	(350,000)
Payments on notes payable	(40,000)
Settlement of notes payable less accrued interest	(1,108,000)
Loss on the forgiveness of debt	$ (37,237)

Note 4 - Related Party Transa_2

Note 4 - Related Party Transactions (Details) - USD ($)		12 Months Ended
	Jun. 08, 2022	Jun. 30, 2022	Jun. 30, 2021
Due to officer		$ 0	$ 6,428
Proceeds from notes payable to shareholders		$ 350,000	$ 1,048,000
July 2019 Note
Aggregate Principal Balance on Converted Notes	$ 1,108,000
January 2021 Note
Accrued Interest on Converted Notes	$ 282,838

Note 7 - Stockholders' Equity_4

Note 7 - Stockholders' Equity (Deficit) (Details) - USD ($)					12 Months Ended
	Oct. 29, 2020	Oct. 21, 2020	Sep. 29, 2020	Jul. 14, 2020	Jun. 30, 2022	Jun. 30, 2021	Jan. 12, 2021
Common Stock, Shares, Issued					148,543,635	135,524,617
Common Stock, Shares, Outstanding					148,543,635	135,524,617
Common stock issued for cash, Value					$ 520,000	$ 120,000
Common stock issued for services, Value					144,141	568,636
Issuance of common stock payable					25,236	25,236
Common stock payable					10,475	0
Stock compensation expense					$ 2,014,612	$ 2,060,245
Options granted					19,407,076	4,094,959
Expense in connection with the options					$ 233,471	$ 488,296
Shares issued for prepayment penalty, Shares	123,602		153,410
Shares issued for prepayment penalty	$ 14,832		$ 30,682		$ 0	(45,514)
Payment of notes payable with issuance of common stock, Value						$ 116,184
Board Members and Consultants
Options granted					8,106,723	4,094,959
Investor | April 2020 Note
Payment of notes payable with issuance of common stock, Value		$ 0.12		$ 0.12
Principal amount		$ 348,000		$ 340,000
Debt Instrument, Convertible, Conversion Price		$ 0.144		$ 0.144
Embedded Conversion Feature		$ 135,333		$ 85,000
Investor | January 2021 Note
Principal amount							$ 360,000
Debt Instrument, Maturity Date							12%
Common Stock
Common stock issued for cash, Shares					5,200,000	1,200,000
Common stock issued for cash, Value					$ 5,200	$ 1,200
Common stock issued for services, Shares					3,819,018	3,265,327
Common stock issued for services, Value					$ 3,819	$ 3,268
Issuance of common stock payable, Shares					140,199	140,199
Issuance of common stock payable						$ 140
Stock compensation expense					$ 4,000	$ 3,000
Shares issued for prepayment penalty, Shares						(277,012)
Shares issued for prepayment penalty						$ (277)
Payment of notes payable with issuance of common stock, Value						$ 604

Note 7 - Stockholders' Equity_5

Note 7 - Stockholders' Equity (Deficit): Schedule of Stock Option Activity (Details) - $ / shares			12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Details
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	23,502,035	4,094,959	23,502,035	4,094,959	0
Weighted Average Exericse Price, Balance	$ 0.11	$ 0.15	$ 0.11	$ 0.15	$ 0
Options granted			19,407,076	4,094,959
Weighted Average Exericse Price, Granted			$ 0.10	$ 0.15
Weighted Average Remaining Life, granted			4 years 9 months 10 days	5 years
Options exercised			0	0
Weighted Average Exericse Price, Exercised				$ 0
Weighted Average Remaining Life, outstanding	2 years 11 months 1 day	5 years

Note 7 - Stockholders' Equity_6

Note 7 - Stockholders' Equity (Deficit): Schedule of Assumptions Used (Details) - $ / shares	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Minimum
Stock Price	$ 0.02
Exercise Price	$ 0.01
Expect term (in years)	1 month 20 days
Volatility (annual)	166%
Risk-free rate	0.04%
Maximum
Stock Price	$ 0.04
Exercise Price	$ 0.36
Expect term (in years)	5 years
Volatility (annual)	201%
Risk-free rate	3.03%
Stock Options | Minimum
Stock Price	$ 0.02	$ 0.11
Exercise Price	$ 0.02	$ 0.22
Expect term (in years)	4 years 11 months 8 days	3 years
Volatility (annual)	141.50%	187%
Risk-free rate	1.39%	0.05%
Stock Options | Maximum
Stock Price	$ 0.03	$ 0.20
Exercise Price	$ 0.34	$ 0.37
Expect term (in years)	5 years	5 years
Volatility (annual)	271.10%	271.10%
Risk-free rate	2.94%	0.12%

Note 8 - Derivative Liability_4

Note 8 - Derivative Liability: Schedule of valuation methodology (Details)	12 Months Ended
	Jun. 30, 2022 $ / shares
Minimum
Stock Price	$ 0.02
Exercise Price	$ 0.01
Expect term (in years)	1 month 20 days
Volatility (annual)	166%
Risk-free rate	0.04%
Maximum
Stock Price	$ 0.04
Exercise Price	$ 0.36
Expect term (in years)	5 years
Volatility (annual)	201%
Risk-free rate	3.03%

Note 8 - Derivative Liability_5

Note 8 - Derivative Liability: Fair Value, Liabilities Measured on Recurring Basis (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Fair Value, Inputs, Level 1
Derivative liabilities	$ 0	$ 0
Fair Value, Inputs, Level 2
Derivative liabilities	0	0
Fair Value, Inputs, Level 3
Derivative liabilities	577,180	28,576
Derivative liabilities	$ 577,180	$ 28,576	$ 248,173

Note 8 - Derivative Liability (

Note 8 - Derivative Liability (Details) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Details
Increase (Decrease) in Derivative Liabilities	$ 130,593	$ 94,356
Derivative liabilities	$ 577,180	$ 28,576	$ 248,173

Note 8 - Derivative Liability_6

Note 8 - Derivative Liability: Schedule of activity for derivative liabilities measured at estimated fair value (Details) - USD ($)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Details
Derivative liabilities	$ 577,180	$ 28,576	$ 248,173
Additions during the period	484,376	0
Change in fair value	67,360	(94,357)
Change due to conversion / exercise / redemption	$ (3,132)	$ (125,240)

Note 9 - Income Taxes (Details)

Note 9 - Income Taxes (Details)	12 Months Ended
	Jun. 30, 2022 USD ($)
Operating Loss Carryforwards	$ 5,445,000
Operating Loss Carryforwards - State	4,053,000
China
Operating Loss Carryforwards	$ 23,000
Operating Loss Carryforwards, Limitations on Use	expire in 2032

Note 9 - Income Taxes_ Schedu_3

Note 9 - Income Taxes: Schedule of Deferred Tax Assets (Details) - USD ($)	Jun. 30, 2022	Jun. 30, 2021
Details
Deferred Tax Assets, Operating Loss Carryforwards	$ 1,427,731	$ 1,078,203
Stock Based Compensation	1,193,811	592,103
Unrealized loss on Debt conversion	10,036	10,036
Deferred Tax Assets, Valuation Allowance	(2,631,578)	(1,680,342)
Deferred Tax Assets, Net of Valuation Allowance	$ 0	$ 0

Note 9 - Income Taxes_ Schedu_4

Note 9 - Income Taxes: Schedule of Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Details
Statutory federal tax rate	21%	21%
State taxes, net of federal benefit	6.26%	3.99%
Non-deductible Stock Compensation	0%	(1.61%)
Other	(0.40%)	0.47%
Valuation Allowance	(26.86%)	(23.85%)
Provision for income taxes	0%	0%